TEVA-TRIACOMB 100000 UNIT — DIN 00550507
NYSTATIN : 100000 UNIT TRIAMCINOLONE ACETONIDE : 1 MG NEOMYCIN (NEOMYCIN SULFATE) : 2.5 MG GRAMICIDIN : 0.25 MG · TEVA CANADA LIMITED · CREAM · wholesale supply in Canada
Health Canada status: MARKETED
What is TEVA-TRIACOMB?
TEVA-TRIACOMB 100000 UNIT contains NYSTATIN : 100000 UNIT TRIAMCINOLONE ACETONIDE : 1 MG NEOMYCIN (NEOMYCIN SULFATE) : 2.5 MG GRAMICIDIN : 0.25 MG. It is listed in the Health Canada Drug Product Database under DIN 00550507, held by TEVA CANADA LIMITED, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 10-Jan-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-TRIACOMB used for?
TEVA-TRIACOMB is indicated for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida. TEVA-TRIACOMB is also indicated for Pruritus ani and pruritus vulvae.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Triamcinolone And Antibiotics cost around the world?
Triamcinolone And Antibiotics is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 12 | 107 | USD███.██ |
| Australia | ex-manufacturer | 5 | 10 | AUD███.██ |
| Italy | prezzo al pubblico (classe A) | 3 | 3 | EUR███.██ |
| Morocco | PPV (public price) | 2 | 3 | MAD███.██ |
| Greece | producer price (ex-factory) | 2 | 2 | EUR███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 1 | 1 | EUR███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
| Italy | ex-factory (classe H) | 1 | 1 | EUR███.██ |
130 pack listings across 29 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every Triamcinolone And Antibiotics pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Triamcinolone And Antibiotics in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Triamcinolone And Antibiotics, across 11 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TARO PHARMACEUTICALS INC | 2 | 2 | VIADERM KC CRM, VIADERM KC ONT | Sourceable in Canada |
| BIMEDA-MTC ANIMAL HEALTH INC | 1 | 1 | THERADERM CREAM | Sourceable in Canada |
| TEVA CANADA LIMITED | 1 | 1 | TEVA-TRIACOMB | Sourceable in Canada |
| WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | 4 | 0 | KENACOMB CREAM, KENACOMB MILD CREAM, KENACOMB MILD OINTMENT, KENACOMB OINTMENT | No marketed DIN |
| LEDERLE CYANAMID CANADA INC. | 1 | 0 | ARISTOFORM R CRM 0.1% | No marketed DIN |
| MEDIC LABORATORY LTÉE | 1 | 0 | MECOMB CRM 0.1% | No marketed DIN |
| SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | 1 | 0 | KENACOMB ONT | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100000 UNIT |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
| Pack configuration (monograph) | 15, 30 and 60 g tubes and in 450 g jars |
| Storage | Store at room temperature, 15 °C – 30 °C. Keep tube tightly closed. Do not freeze. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Triamcinolone And Antibiotics |
|---|---|
| ATC code | D07CB01 |
| AHFS class | 84:06.00 ; 84:04.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00550507 |
|---|---|
| DIN (unpadded, as printed on some documents) | 550507 |
| Brand name | TEVA-TRIACOMB |
| Generic / active ingredient | NYSTATIN : 100000 UNIT TRIAMCINOLONE ACETONIDE : 1 MG NEOMYCIN (NEOMYCIN SULFATE) : 2.5 MG GRAMICIDIN : 0.25 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | D07CB01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D07CB |
| Current status | MARKETED |
| Status date | 10-Jan-2018 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Triamcinolone And Antibiotics in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by STERIMAX INC (Tier 3 Drug Shortages About & Resources), last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
4 of 11 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| THERADERM CREAM | 2.5 MG | CREAM | BIMEDA-MTC ANIMAL HEALTH INC | MARKETED | 02022818 |
| VIADERM KC CRM | 0.10% | CREAM | TARO PHARMACEUTICALS INC | MARKETED | 00717002 |
| VIADERM KC ONT | 2.5 MG | OINTMENT | TARO PHARMACEUTICALS INC | MARKETED | 00717029 |
| ARISTOFORM R CRM 0.1% | 1 MG | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00128058 |
| KENACOMB CREAM | 2.5 MG | CREAM | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 01999850 |
| KENACOMB MILD CREAM | 2.5 MG | CREAM | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 01999842 |
| KENACOMB MILD OINTMENT | .25 MG | OINTMENT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 01999834 |
| KENACOMB OINTMENT | .25 MG | OINTMENT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 01999826 |
| KENACOMB ONT | 2.5 MG | OINTMENT | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 00245267 |
| MECOMB CRM 0.1% | .25 MG | CREAM | MEDIC LABORATORY LTÉE | CANCELLED POST MARKET | 00464554 |
2 · Same class — other molecules in ATC D07CB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Triamcinolone And Antibiotics | ARISTOFORM R CRM 0.1% · KENACOMB CREAM · KENACOMB MILD CREAM · KENACOMB MILD OINTMENT · +7 more | 11 | 4 | Yes |
| Flumetasone And Antibiotics | LOCACORTEN VIOFORM | 2 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D07C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D07CA | Hydrocortisone And Antibiotics · Methylprednisolone And Antibiotics | 8 | 2 |
| D07CC | Betamethasone And Antibiotics · Fluocinonide And Antibiotics | 6 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TEVA-TRIACOMB called?
The same molecule, Triamcinolone And Antibiotics, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Kenacomb Otic | Latin | Australia |
| KENACORT RETARD | Latin | Morocco |
| Otocomb Otic | Latin | Australia |
| Tricortone | Latin | Australia |
| Kenalog in orabase | Latin | South Africa |
| Nasacor T | Latin | South Africa |
| NASACORT | Latin | Morocco |
| Volon A | Latin | Iceland |
| Volon A Haftsalbe | Latin | Austria |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.